Prolonged survival after bevacizumab rechallenge in glioblastoma patients with previous response to bevacizumab(†)

BACKGROUND. The use of bevacizumab for recurrent glioblastoma is controversial. Here we show data on patients who responded to bevacizumab, then stopped bevacizumab for any reason other than progression and were rechallenged with bevacizumab at the time of subsequent progression. METHODS. This retro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neurooncol Pract
Autores principales: Balaña, Carmen, Estival, Anna, Pineda, Estela, Sepúlveda, Juan, Mesía, Carles, del Barco, Sonia, Gil-Gil, Miguel, Hardy, Max, Indacoechea, Alberto, Cardona, Andrés Felipe
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2017
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6655406/
https://ncbi.nlm.nih.gov/pubmed/31385992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npw004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares